Patent · US Active

Antibodies against human CSF-1R and uses thereof

US10077314B1 · kind B1 · utility

5Cited by

35References

20Claims

0Family size

Inventors

Nikolaos Dimoudis · Wielenbach, DE
Georg Fertig · Penzberg, DE
Alexander Fidler · Penzberg, DE
Klaus Kaluza · Bad Heilbrunn, DE
Martin Lanzendoerfer · Tutzing, DE
Carola Ries · Penzberg, DE
Stefan Seeber · Penzberg, DE
Marlene Thomas · Penzberg, DE

Key dates

Filing date	Jan 19, 2018
Grant date	Sep 18, 2018
Priority date	—
Expiry date	Jan 19, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to antibodies against human CSF-1R (anti-CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.